NASDAQ: BOLD
Boundless Bio Inc Stock Ownership - Who owns Boundless Bio?

Insider buying vs selling

Have Boundless Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BOLD insiders and whales buy or sell their stock.

BOLD Shareholders

What type of owners hold Boundless Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC12.00%2,695,455$3.80MInstitution
Citadel Advisors LLC5.97%1,342,131$1.89MInstitution
Arch Venture Fund IX LP5.26%1,181,766$1.67MInsider
Keith Crandell5.26%1,181,766$1.67MInsider
Kristina Burow5.26%1,181,766$1.67MInsider
Sectoral Asset Management Inc3.02%678,574$956.79kInstitution
Jonathan E. Lim2.91%653,479$921.41kInsider
Stonepine Capital Management LLC2.66%597,682$842.73kInstitution
Vanguard Capital Management LLC2.66%597,192$842.04kInstitution
Wellington Management Group LLP2.48%556,233$784.29kInstitution

1 of 3

BOLD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BOLD37.78%23.74%
LSTA1.19%98.81%Net Selling
ATNM14.66%85.34%Net Selling
RADX2.17%7.66%
ALGS6.77%93.23%

Boundless Bio Stock Ownership FAQ

Who owns Boundless Bio?

Boundless Bio (NASDAQ: BOLD) is owned by 37.78% institutional shareholders, 23.74% Boundless Bio insiders, and 38.48% retail investors. Arch Venture Fund IX LP is the largest individual Boundless Bio shareholder, owning 1.18M shares representing 5.26% of the company. Arch Venture Fund IX LP's Boundless Bio shares are currently valued at $1.65M.

If you're new to stock investing, here's how to buy Boundless Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.